In addition, transcriptional activation of SRSF2 via E2F1 was shown to be partly responsible for AS of VEGF in favor of the anti-angiogenic isoform (i.e. VEGF165b), and was confirmed, in vivo, that this splice switch was able to reduce tumor neovascularization (41). This evidence concerns the gene VEGFA and neoplasm.